Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma

被引：3
|
作者：
Limaye, Sewanti [1 ]
Patil, Darshana [2 ]
Akolkar, Dadasaheb [2 ]
Srivastava, Navin [2 ]
Patil, Revati [2 ]
Apurwa, Sachin [2 ]
Patil, Sanket [2 ]
John, Jinumary [2 ]
Gosavi, Rahul [2 ]
Nesargikar, Prabhu [3 ]
Kumar, Prashant [4 ,5 ,6 ]
Datta, Vineet [2 ]
Bose, Chirantan [2 ]
Raazi, Zarrine [2 ]
Srinivasan, Ajay [2 ]
Datar, Rajan [2 ]
机构：
[1] Kokilaben Dhirubhai Ambani Hosp & Med Res Inst, Mumbai, Maharashtra, India
[2] Datar Canc Genet, Nasik 422010, Maharashtra, India
[3] HCG Canc Ctr, Bengaluru, Karnataka, India
[4] Inst Bioinformat, Bengaluru, Karnataka, India
[5] Manipal Acad Higher Educ, Manipal, Karnataka, India
[6] Somaiya Vidyavihar Univ, Somaiya Inst Res & Consultancy, Mumbai, Maharashtra, India
来源：
CLINICAL CASE REPORTS | 2021年 / 9卷 / 11期
关键词：
combination regimen; encyclopedic tumor analysis; gastric adenocarcinoma; pazopanib; personalized cancer treatment; precision oncology; stomach cancer; PLUS CAPEOX CAPECITABINE; GEMCITABINE COMBINATION; KINASE INHIBITOR; PHASE-II; CANCER; LAROTRECTINIB; CARCINOMA; PATIENT; GROWTH; FUSION;
D O I：
10.1002/ccr3.4986
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti-cancer agents for treatment of Gastric cancers.
引用
收藏
页数：5
相关论文
共 11 条
  • [1] Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification
    Palma, Norma
    Morris, John C.
    Ali, Siraj M.
    Ross, Jeffrey S.
    Pal, Sumanta Kumar
    EUROPEAN UROLOGY, 2015, 68 (01) : 168 - 170
  • [2] Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports
    Quinzii, Alberto
    Zecchetto, Camilla
    Casalino, Simona
    Gaule, Marina
    Pesoni, Camilla
    Merz, Valeria
    Contarelli, Serena
    Pietrobono, Silvia
    Benhadji, Karim A.
    Melisi, Davide
    CLINICAL DRUG INVESTIGATION, 2022, 42 (08) : 697 - 701
  • [3] Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports
    Alberto Quinzii
    Camilla Zecchetto
    Simona Casalino
    Marina Gaule
    Camilla Pesoni
    Valeria Merz
    Serena Contarelli
    Silvia Pietrobono
    Karim A. Benhadji
    Davide Melisi
    Clinical Drug Investigation, 2022, 42 : 697 - 701
  • [4] Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report
    Ding, Xinjia
    Zong, Jianguo
    Li, Xiang
    Bai, Xiaoyan
    Tan, Bowen
    Sun, Weibing
    Wang, Ruoyu
    Ding, Yan
    ONCOTARGETS AND THERAPY, 2021, 14 : 2177 - 2183
  • [5] A refractory case ofCDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report
    Lin, Jietao
    Yu, Ling
    Fu, Yuanfeng
    Chen, Hanrui
    Zheng, Xinting
    Wang, Shutang
    Gao, Chan
    Cao, Yang
    Lin, Lizhu
    BMC CANCER, 2020, 20 (01)
  • [6] A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report
    Jietao Lin
    Ling Yu
    Yuanfeng Fu
    Hanrui Chen
    Xinting Zheng
    Shutang Wang
    Chan Gao
    Yang Cao
    Lizhu Lin
    BMC Cancer, 20
  • [7] Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-I Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report
    Yu, Shanshan
    Cai, Luya
    Lin, Fan
    Wu, Xueyuan
    Zhang, Cheng
    Liu, Xuan
    Li, Wenfeng
    ONCOTARGETS AND THERAPY, 2019, 12 : 7691 - 7698
  • [8] Response to immunotherapy, platinum-based chemotherapy or their combination in metastatic urothelial carcinoma (MUC) with or without FGFR-3 alterations: Single cohort experience
    Ferrer-Mileo, Laura
    Rodriguez, Adela
    Gonzalez, Nuria
    Orrillo, Mayra
    Jimenez, Natalia
    Marin-Aguilera, Mercedes
    Rodriguez-Carunchio, Leonardo
    Prat, Aleix
    Mellado, Begona
    Reig, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report
    Niu, Xiaomin
    Sun, Yingjia
    Planchard, David
    Chiu, Luting
    Bai, Jian
    Ai, Xinghao
    Lu, Shun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Genetic polymorphism of XRCC3 codon 241 and Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi Population, China: A hospital-based case-control study
    Zhao, Lei
    Long, Xi-Dai
    Yao, Jin-Guang
    Wang, Chao
    Ma, Yun
    Huang, Yong-Zhi
    Li, Yun-Qian
    Wang, Min-Fa
    Fu, Guo-Hui
    CANCER EPIDEMIOLOGY, 2011, 35 (06) : 564 - 568
12